Logo: to the web site of Uppsala University

uu.sePublikasjoner fra Uppsala universitet
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The Role of Circulating Angiogenic Factors in Patients Operated on for Localized Malignant Melanoma
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi, Enheten för onkologi.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi. (Lunggruppen)
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för medicinska vetenskaper, Klinisk kemi. (Biologisk struktur och funktion)
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi. (Lymfomgruppen)
Vise andre og tillknytning
2007 (engelsk)Inngår i: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 27, nr 5A, s. 3211-3217Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Malignant melanoma is a disease capable of rapid progression and rapidly developing metastases. Angiogenesis is a key event signalling tumour progression and elevated levels of angiogenic markers may indicate metastatic disease. No previously published work has, so far, examined plasma vascular endothelial growth factor (VEGF) and its receptor, VEGFR-1, in melanoma. This study investigated circulating levels of the angiogenic factors, VEGF-A and -D, their receptors 1-3 and hepatocyte growth factor (HGF)/scatter factor, in patients shortly after primary surgery for localized malignant melanoma. Elevated circulating levels of VEGF and its receptors, and of HGF, were found postoperatively, possibly derived from the reactive stroma adjacent to the tumours. Using univariate analysis, a correlation between levels of VEGFR-1 and relapse was found, but a correlation between the investigated angiogenic factors and survival could not be established. The results of the present study indicate that production of these angiogenic factors may be due to sources other than malignant melanoma cells.

sted, utgiver, år, opplag, sider
2007. Vol. 27, nr 5A, s. 3211-3217
Emneord [en]
Malignant melanoma, angiogenesis, survival, relapse, vascular endothelial growth factor, hepatocyte growth factor, hepatocyte scatter factor
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-97931ISI: 000250266600022PubMedID: 17970063OAI: oai:DiVA.org:uu-97931DiVA, id: diva2:173055
Tilgjengelig fra: 2008-12-22 Laget: 2008-12-22 Sist oppdatert: 2017-12-14bibliografisk kontrollert
Inngår i avhandling
1. Prognostic Factors in Malignant Melanoma
Åpne denne publikasjonen i ny fane eller vindu >>Prognostic Factors in Malignant Melanoma
2008 (engelsk)Doktoravhandling, med artikler (Annet vitenskapelig)
Abstract [en]

Because of the failure so far to find effective treatment for patients with advanced stages of melanoma, increasing efforts have been made to find prognostic factors identifying patients in the risk zone for development of metastasis.

This thesis investigates the prognostic powers of a few selected serological and immunohistochemical biomarkers.

In the first and second study, patients operated on for localized malignant melanoma were investigated regarding the prognostic impact of angiogenic serological markers and circulating levels of S100. We concluded that the S100 assays, especially S100BB, are potential biomarkers in patients with malignant melanoma, correlated to both survival and disease free survival. However, no such conclusion could be drawn from the first study, where we found no correlation to survival and investigated angiogenic markers.

In the third and fourth study four new potential immunohistochemical biomarkers where investigated in collaboration with the Swedish Human Protein Atlas Program, and those where TRP-1, galectin-1, DLG5 and syntaxin-7.

We found that TRP-1 correlated inversely with tumor stage and galectin-1 correlated to Ki-67.

DLG5 showed a significant inverse correlation to Ki67 and the expression of STX7 was inversely correlated to tumor stage, suggesting that decreased expression is associated with more aggressive tumors.

None of the investigated markers in study III and IV correlated with disease free survival or overall survival.

In the fifth and last study, we examined the expression of SOX10, a transcription factor, in different melanocytic lesions. Also, a proliferation assay was carried out in a human melanoma cell line. The results reveal the presence of SOX10 in different melanocytic lesions, with a weak inverse correlation to survival and a significant inverse correlation to T-stage. A significant decrease in proliferation rate for SOX10 silenced cells was found and our data also suggests an increased migratory response in SOX10 silenced cells.

sted, utgiver, år, opplag, sider
Uppsala: Universitetsbiblioteket, 2008. s. 69
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 410Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 410
Emneord
Malignant melanoma, prognostic factors, survival, chemotherapy, radiation
Identifikatorer
urn:nbn:se:uu:diva-9511 (URN)978-91-554-7378-5 (ISBN)
Disputas
2009-01-16, Skoog Salen, Onkologkliniken, ing 78, Uppsala Universitetssjukhus, 751 85, Uppsala, 09:15
Opponent
Veileder
Tilgjengelig fra: 2008-12-22 Laget: 2008-12-22 Sist oppdatert: 2013-06-20bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

PubMed

Person

Wagenius, GunnarLarsson, AndersBrattström, DanielUllenhag, GustavHesselius, PatrikBergqvist, Michael

Søk i DiVA

Av forfatter/redaktør
Wagenius, GunnarLarsson, AndersBrattström, DanielUllenhag, GustavHesselius, PatrikBergqvist, Michael
Av organisasjonen
I samme tidsskrift
Anticancer Research

Søk utenfor DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric

pubmed
urn-nbn
Totalt: 871 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf